17.5% Growth Rate for Global Cystic Fibrosis Market by 2026 | AbbVie, Inc. (US), Aradigm Corporation (US), Aurora Bioscience (Australia), Bayer AG (Germany), Demegen, Inc. (US), EryDel SPA (Italy)

Global Cystic Fibrosis Market is expected to rise gradually to an estimated value of USD 17.62 billion by 2026, registering a CAGR of 17.5% in the forecast period of 2019-2026

Market Analysis: Global Cystic Fibrosis Market

Global Cystic Fibrosis Market is expected to rise gradually to an estimated value of USD 17.62 billion by 2026, registering a CAGR of 17.5% in the forecast period of 2019-2026 with the annual sales of USD 4.85 billion in the year 2018. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of patients.

Global Cystic Fibrosis Market By Therapy Type , Route of administration , End- users ,Geography 

Request Free Sample Report at @

Market Definition: Global Cystic Fibrosis Market

Cystic Fibrosis is an autosomal recessive disorder with the mutation of CFTR (cystic fibrosis transmembrane conductance regulator) gene. This gene regulates the exchange of ions across the epithelial cells and the mutation in this gene affects most of the organs including lungs, liver, pancreas and intestine.

According to European Cystic Fibrosis Society, around 44,000 people are suffering from cystic fibrosis from 2008 to 2016 where almost more than half of these cases could have been avoided with the availability of proper medical equipment and devices for healthcare procedures. This significant number is expected to act as a driver to the market growth.

Key Market Competitors: Global Cystic Fibrosis Market

Few of the major competitors currently working in the cystic fibrosis market are AbbVie, Inc. (US), Aradigm Corporation (US), Aurora Bioscience (Australia), Bayer AG (Germany), Demegen, Inc. (US), EryDel SPA (Italy), Genentech, Inc. (US), nDex Pharmaceuticals Holding AB (Sweden), ManRos Therapeutics (France), Novartis AG (Switzerland), Polydex Pharmaceuticals Limited. (Canada), F. Hoffmann-La Roche AG (Switzerland), Vertex Pharmaceuticals Incorporated (US) and few among others.

Potential of the report:

• To gain information about the top players in this industry, their product portfolios, and their key strategies.
• Key parameters which are driving this market and restraining its growth
• What all challenges manufacturers will face as well as new opportunities and threats faced by them.
• Learn about the market strategies that are being adopted by your competitors and leading organizations
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

Table of Contents

  • Part 01: Executive Summary
  • Part 02: Scope Of The Report
  • Part 03: Global Cystic Fibrosis Market Landscape
  • Part 04: Global Cystic Fibrosis Market Sizing
  • Part 05: Global Cystic Fibrosis Market Segmentation Therapy Type
  • Part 06: Five Forces Analysis
  • Part 07: Customer Landscape
  • Part 08: Geographic Landscape
  • Part 09: Decision Framework
  • Part 10: Drivers And Challenges
  • Part 11: Market Trends
  • Part 12: Vendor Landscape
  • Part 13: Vendor Analysis

Request Complete TOC Of this Report @

Competitive Analysis: Global Cystic Fibrosis Market

Global cystic fibrosis market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cystic fibrosis market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Drivers

  • Increase in prevalence rate of cystic fibrosis worldwide.
  • Rising awareness about cystic fibrosis therapy and technological advancement is driving the growth of market.
  • Increase in the rate of R&D initiatives is driving cystic fibrosis therapeutics market.

Market Restraints

  • High cost involved in the treatment.
  • Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market.

Segmentation: Global Cystic Fibrosis Market

By Therapy Type

  • CFTR modulators
  • Mucolytic
  • Bronchodilators
  • Protein Transcription Modulators
  • Pancreatic enzyme supplements
  • Others

By Route of administration

  • Oral
  • Inhaled drugs

By End users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Geography

  • North America
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific
  • Middle East & Africa
    • South Africa
    • Egypt
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Rest of Middle East & Africa

Grab Your Report at an Impressive Discount!

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge Market Research
Tel: +1-888-387-2818


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *